Advertisement

Langenbeck's Archives of Surgery

, Volume 388, Issue 5, pp 344–346 | Cite as

Muscle reconstruction in reconstructive surgery: soft tissue repair and long bone reconstruction

  • A. C. MasqueletEmail author
Musculoskeletal Soft Tissue Conditioning

Abstract

Background

We report a series of reconstructions of long bone defects in 35 patients. Bone defects ranged from 5.0 to 25.0 cm.

Method

Reconstruction was performed in two stages. The first stage was the insertion into the defect of a cement spacer, which was responsible for the formation of a pseudosynovial membrane. A soft tissue repair employing a flap was done in the same operating time in 28 cases. The second stage was the reconstruction of the bone defect by a large, fresh, autologous cancellous bone graft.

Results

The membrane induced by the spacer prevents the resorption of the graft and favours its revascularisation and its corticalisation. Experimental study has also shown that the membrane plays the role of an "in situ growth-factors delivery system".

Conclusion

In weight-bearing diaphyseal segments normal walking was possible at 8.5 months on average.

Keywords

Bone reconstruction Growth factors Cancellous bone graft Pseudosynovial membrane 

References

  1. 1.
    Holden CEA (1972) The role of blood supply to soft tissue in the healing of diaphyseal fractures. J Bone Joint Surg Am 52:993–1000Google Scholar
  2. 2.
    Fischer J, Wood MB (1987) Experimental comparison of bone revascularization by musculocutaneous and cutaneous flaps. Plast Reconstr Surg 79:81–90PubMedGoogle Scholar
  3. 3.
    Chang N, Mathes SJ (1982) Comparison of the effect of bacterial inoculation in musculocutaneous and random pattern flaps. Plast Reconstr Surg 70:1–9PubMedGoogle Scholar
  4. 4.
    Irons GB, Fischer J, Schmitt EH (1984) Vascularized muscular and musculocutaneous flap for management of osteomyelitis. Orthop Clin North Am 15:473–480PubMedGoogle Scholar
  5. 5.
    Weiland AJ, Moore RJ, Daniel RK (1984) The efficacy of free tissue transfer in the treatment of osteomyelitis. J Bone Joint Surg Am 66:181–193Google Scholar
  6. 6.
    Han CS, Wood MB, Bishop AT, Cooney WP (1992) Vascularized bone transfer. J Bone Joint Surg Am 74:1441–1449Google Scholar
  7. 7.
    May JN, Jupiter JB, Weiland AJ (1989) Clinical classification of post-traumatic tibial osteomyelites. J Bone Joint Surg Am 71:1422–1428PubMedGoogle Scholar
  8. 8.
    Weiland AJ (1981) Current concepts review: vascularized free bone transplants. J Bone Joint Surg Am 63:166–169PubMedGoogle Scholar
  9. 9.
    Cattaneo R, Catagni M, Johnson EF (1992) The treatment of infected nonunions and segmental defects of the tibia by the method of Ilizarov. Clin Orthop 280:143–152PubMedGoogle Scholar
  10. 10.
    Cook SD, Barrack RL, Santman M, Patron LP, Sakeld SL, Whitecloud TS (2000) Strut allograft healing to the femur with recombinant human osteogenic protein-1. Chin Orthop 381:47–57Google Scholar
  11. 11.
    Salked SL, Patron LR, Barrack RL, Cook SD (2001) The effect of osteogenic protein-1 on the healing of segmental bone defects treated with autograft or allograft bone. J Bone Joint Surg Am 83:803–816Google Scholar
  12. 12.
    Friedlander GE, Perry CR, Cole JD, Cook SD, et al (2001) Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial non unions. J Bone Joint Surg Am 83:151–158Google Scholar
  13. 13.
    Urist MR, Delange RJ, Finerman GA (1983) Bone cell differentiation and growth factors. Science 220:680–686PubMedGoogle Scholar
  14. 14.
    Masquelet AC, Fitoussi F, Begue T, Muller GP (2000) Reconstruction des os longs par membrane induite et autogreffe spongieuse. Ann Chir Plast Esthet 45:346–353PubMedGoogle Scholar
  15. 15.
    Pelissier P, Masquelet AC, Lepreux S, Martin D, Baudet J (2002) Behaviour of cancellous bone graft placed in induced membrane. A case report. Br J Plast Surg 55:598–600CrossRefPubMedGoogle Scholar
  16. 16.
    Deckers M, Karperien M, Vanderbent C (2000) Expression of vascular endothelial growth factors and their receptors during osteoblasts differentiation. Endocrinology 141:1667–1674PubMedGoogle Scholar
  17. 17.
    Pfeilschifter J, Diel I, Scheppach B (1998) Concentration of transforming growth factor beta in human bone tissue: relationships to age, menopause, bone turnover and bone volume. J Bone Miner Res 13:716–730PubMedGoogle Scholar
  18. 18.
    Riley EH, Lane JM, Urist MR, Lyon KM, Lieberman JR (1996) Bone morphogenetic protein-2: biology and application. Chin Orthop 324:39–46Google Scholar

Copyright information

© Springer-Verlag 2003

Authors and Affiliations

  1. 1.Department of Orthopaedic and Reconstructive SurgeryHôpital AvicenneBobigny CedexFrance

Personalised recommendations